Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Astrocytoma × Everolimus × Clear all

Phase

Phase 2 4 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Carcinoma, Renal Cell 8 Neuroendocrine Tumors 6 Neoplasm Metastasis 3 Kidney Neoplasms 3 Tuberous Sclerosis 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Carcinoma 2 Carcinoid Tumor 2 von Hippel-Lindau Disease 1 Tuberous Sclerosis Complex-associated Refractory Seizures 1 Thymus Neoplasms 1 Stomach Diseases 1 Skin Neoplasms 1 Seizures 1 Renal Cell Cancer Metastatic 1 Prostatic Neoplasms 1 Primary Non-metastatic Breast Cancer 1 Polycystic Kidney, Autosomal Dominant 1 Malignant Carcinoid Syndrome 1 HER2+ Breast Cancer 1 Fibrosis 1 Digestive System Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Cysts 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Temozolomide 16 Radiotherapy 11 Lomustine 8 Carmustine 6 Vincristine 5 Procarbazine 5 Etoposide 3 Corticotropin-Releasing Hormone 3 Carboplatin 3 vorasidenib 2 Thiotepa 2 Radiotherapy, Intensity-Modulated 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Isotretinoin 2 Dihematoporphyrin Ether 2 Cisplatin 2 Chemotherapy, Adjuvant 2 etoposide phosphate 1 carmustine, poliferprosan 20 drug combination 1 Valproic Acid 1 Tranexamic Acid 1 Trabedersen 1 Thioguanine 1 Surgical Procedures, Operative 1 Semustine 1 Radiotherapy, Conformal 1 Radiosurgery 1 Prednisone 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00789828 2016-02-03

EXIST-1

Novartis

Phase 3 Completed

117 enrolled 15 charts

Astrocytoma, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡